Skip to main content
Caplight Logo









Reneural

Reneural

Private
HatfieldHealthcare & Life Scienceshttps://reneural.tech/

Last Round

Grant

Nov 6, 2024

Total Funding Raised

$1.02M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Reneural operates in Healthcare & Life Sciences and is based in Hatfield. Its latest recorded funding round was a Grant round in November 2024.

Reneural is a neurotech company that develops a neurorehabilitation platform using virtual reality designed for stroke survivors.

Sector

Healthcare & Life Sciences

Verticals

AR/VR Experiences, Medical Devices, Mental Health, Patient Engagement

Business Model

B2B

Customer Profile

Hardware + Subscription, Government Contracts

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Reneural Comparables

Compare Reneural with similar companies based on industry and business-model similarity.

Reneural comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
eXRt Intelligent Healthcare
92%
Eodyne Systems
84%
Neuro Rehab VR
82%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Reneural Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantNov 6, 2024
Pre SeedNov 6, 2024
GrantNov 1, 2022
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Reneural Investors

Notable investors and investment history

Reneural investors
InvestorRounds
Innovate UKGrant, Pre Seed
SFC CapitalPre Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 20, 2026

    Monthly visitors increased 643% MoM, reaching 572.

  • Apr 15, 2026

    Monthly visitors grew 141% MoM, reaching 2.6K.

Book a demo to see all signals

For institutional investors. Book with your work email.

Reneural Filings

Explore SEC and related filing metadata, where available.

Reneural filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Reneural's valuation, stock price, and market status.

Is Reneural a public or private company?

Reneural is a private company.

What is the current stock price of Reneural?

Reneural is a private company, so its shares have no public market price. Caplight tracks Reneural's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Reneural worth (valuation)?

Valuation information for Reneural is not publicly available.

Can I buy Reneural stock?

Reneural shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Reneural's last funding round?

Reneural's most recent funding round was Grant on November 6, 2024.

Who are the main investors in Reneural?

Key investors in Reneural include SFC Capital.

Will Reneural IPO soon?

No public IPO plans have been announced for Reneural.

How can I track Reneural secondary market activity?

Caplight tracks bids, offers, and trades in Reneural's shares on secondary markets.

Firmographic Details

HeadquartersHatfield
Employee Range3
Year Founded2022
Last FundingNov 6, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?